A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

NCT06100289 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis
Crohn's Disease

Interventions

DRUG: Vedolizumab IV
DRUG: Vedolizumab SC

Sponsor

Takeda